Help Us

With Research Into a New HIV Prevention Approach


Get AMP'd

For HIV Prevention


State Anti-Transgender ‘Bathroom Bills’ Threaten Transgender People’s Health, Participation In Public Life


The Fenway Institute at Fenway Health works to make life healthier for those who are lesbian, gay, bisexual, and transgender (LGBT) , people living with HIV/AIDS, and the larger community. We do this through research and evaluation, education and training, and public health advocacy.

The Fenway Institute is an interdisciplinary center for research, training, education, and policy development, focusing on national and international health issues.  Our mission is to ensure access to quality, culturally competent medical and mental health care for traditionally underserved communities, including lesbian, gay, bisexual and transgender (LGBT) people and those affected by HIV/AIDS.

We do this by conducting innovative research and developing education and advocacy programs grounded in the LGBT community.  We act as a catalyst for change in the larger community by applying our knowledge broadly. We are motivated by the belief that everyone, everywhere deserves access to high-quality, culturally-competent health care.

We conduct policy research on issues affecting LGBT health, HIV policy, hepatitis, sexually transmitted infections, tuberculosis, and other issues.

Providing LGBT health educational programming for health care organizations throughout the nation and the world

Ensuring LGBT older adults have access to life-prolonging benefits, protections, services and institutions

I AM: Trans People Speak

Fenway Health’s contribution to the “I Am: Trans People Speak” campaign, which raises awareness of the diversity across the transgender community. Members of the Fenway community share their experiences as trans individuals and their commitment to being trans allies.

Ansin Building

1340 Boylston Street
Boston, MA 02215



Summer Institute in LGBT Population Health

The Summer Institute in LGBT Population Health will not be offered in 2018.